指南与共识消化、代谢与肾脏急症重症综合管理与镇静镇痛

重症监护医学会与美国卫生系统药师协会指南:危重成人应激相关性胃肠道出血的预防

Society of Critical Care Medicine and American Society of Health-System Pharmacists Guideline for the Prevention of Stress-Related Gastrointestinal Bleeding in Critically Ill Adults.
指南 / 共识 · Crit Care Med · 2024-07-15
一句话结论指南推荐:有凝血障碍、休克或慢性肝病等危险因素的ICU成人应接受低剂量质子泵抑制剂或组胺-2受体拮抗剂预防应激性溃疡出血。

该指南由18名国际多专业专家和2名方法学家依据GRADE方法制定,针对13个PICO问题系统评价证据,形成9条条件推荐和4条良好实践声明。可能增加临床重要应激相关性上消化道出血风险的因素包括凝血障碍、休克和慢性肝病;单纯机械通气无确切证据为危险因素。肠内营养可能降低出血风险。所有具有可能增加风险因素的危重成人应接受低剂量质子泵抑制剂或组胺-2受体拮抗剂预防。当危重状态不再明显或危险因素消失时应停用预防;转出ICU前必须停用应激性溃疡预防。

要点

  • 可能增加临床重要应激相关性上消化道出血风险的因素:凝血障碍、休克、慢性肝病;单纯机械通气无确切证据为危险因素。
  • 所有具有上述危险因素的危重成人应接受质子泵抑制剂或组胺-2受体拮抗剂低剂量方案预防上消化道出血。
  • 肠内营养可能降低上消化道出血风险。
  • 当危重状态不再明显或危险因素不再存在(即使危重状态持续)时应停用预防。
  • 转出ICU前必须停用应激性溃疡预防,以防止不恰当处方。

适用人群与场景

  • ICU成人患者。
  • 具有可能增加临床重要应激相关性上消化道出血风险因素(凝血障碍、休克、慢性肝病)的危重成人。

诊断标准与关键阈值

  • 可能增加临床重要应激相关性上消化道出血风险的因素:凝血障碍、休克、慢性肝病。
  • 单纯机械通气无确切证据为危险因素。

处置流程与药物剂量

  • 所有具有可能增加应激相关性上消化道出血风险因素的危重成人应接受质子泵抑制剂或组胺-2受体拮抗剂低剂量方案预防上消化道出血。
  • 当危重状态不再明显或危险因素不再存在(即使危重状态持续)时,应停用应激性溃疡预防。
  • 转出ICU前必须停用应激性溃疡预防,以防止不恰当处方。

研究设计与关键结果

  • 指南专家组由来自营养学、重症医学、护理和药学领域的18名国际专家及2名方法学家组成,依据GRADE方法制定推荐。
  • 专家组确定并构建了13个PICO问题,对每个问题进行系统评价,采用GRADE方法评估证据确定性,并使用证据-决策框架形成推荐。
  • 专家组产生9条条件推荐和4条良好实践声明。
  • 可能增加临床重要应激相关性上消化道出血风险的因素包括凝血障碍、休克和慢性肝病;单纯机械通气无确切证据为危险因素。
  • 肠内营养可能降低上消化道出血风险。

证据类型、等级与局限

  • 证据类型:指南(依据GRADE方法制定的循证推荐)。
  • 推荐强度:9条条件推荐,4条良好实践声明。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对具有凝血障碍、休克或慢性肝病的ICU成人,应使用低剂量质子泵抑制剂或组胺-2受体拮抗剂预防应激相关性上消化道出血。
  • 不应仅因机械通气而启动应激性溃疡预防(无确切证据为危险因素)。
  • 当危重状态不再明显或危险因素消失时停用预防;转出ICU前必须停用应激性溃疡预防。
  • 这些推荐需结合患者现有临床状态进行考虑。

指南或共识出处

  • 指南名称:Society of Critical Care Medicine and American Society of Health-System Pharmacists Guideline for the Prevention of Stress-Related Gastrointestinal Bleeding in Critically Ill Adults
  • 发布机构:Society of Critical Care Medicine 与 American Society of Health-System Pharmacists
  • 期刊:Critical Care Medicine

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

RATIONALE: Critically ill adults can develop stress-related mucosal damage from gastrointestinal hypoperfusion and reperfusion injury, predisposing them to clinically important stress-related upper gastrointestinal bleeding (UGIB).

OBJECTIVES: The objective of this guideline was to develop evidence-based recommendations for the prevention of UGIB in adults in the ICU.

DESIGN: A multiprofessional panel of 18 international experts from dietetics, critical care medicine, nursing, and pharmacy, and two methodologists developed evidence-based recommendations in alignment with the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology. Conflict-of-interest policies were strictly followed during all phases of guideline development including task force selection and voting.

METHODS: The panel members identified and formulated 13 Population, Intervention, Comparison, and Outcome questions. We conducted a systematic review for each question to identify the best available evidence, statistically analyzed the evidence, and then assessed the certainty of the evidence using the GRADE approach. We used the evidence-to-decision framework to formulate the recommendations. Good practice statements were included to provide additional guidance.

RESULTS: The panel generated nine conditional recommendations and made four good practice statements. Factors that likely increase the risk for clinically important stress-related UGIB in critically ill adults include coagulopathy, shock, and chronic liver disease. There is no firm evidence for mechanical ventilation alone being a risk factor. Enteral nutrition probably reduces UGIB risk. All critically ill adults with factors that likely increase the risk for stress-related UGIB should receive either proton pump inhibitors or histamine-2 receptor antagonists, at low dosage regimens, to prevent UGIB. Prophylaxis should be discontinued when critical illness is no longer evident or the risk factor(s) is no longer present despite ongoing critical illness. Discontinuation of stress ulcer prophylaxis before transfer out of the ICU is necessary to prevent inappropriate prescribing.

CONCLUSIONS: The guideline panel achieved consensus regarding the recommendations for the prevention of stress-related UGIB. These recommendations are intended for consideration along with the patient's existing clinical status.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. MacLaren R, Dionne JC, Granholm A, et al. Society of Critical Care Medicine and American Society of Health-System Pharmacists Guideline for the Prevention of Stress-Related Gastrointestinal Bleeding in Critically Ill Adults. Crit Care Med. 2024. PMID: 39007578. doi:10.1097/CCM.0000000000006330

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。